Yeoun-Hee Kim

Dr. Yeoun-Hee Kim

Etnova Therapeutics Corp., Seongnam-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Cancer Letters
Verified
Journal Article
Closed access
TLTae-Jin Lee
Tae-Jin Lee
OKOn Hee Kim
On Hee Kim
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
JLJun Hee Lim
Jun Hee Lim
SKShin Kim
Shin Kim
TKTaeg Kyu Kwon
Taeg Kyu Kwon

1 March 2008 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
EJEun Mi Jung
Eun Mi Jung
TLTae-Jin Lee
Tae-Jin Lee
SKSang Hyun Kim
Sang Hyun Kim
YCYung Hyun Choi
Yung Hyun Choi
TKTaeg Kyu Kwon
Taeg Kyu Kwon

6 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HLHyeji LEE
Hyeji LEE
KBKanghye Bae
Kanghye Bae
ABAhrum Baek
Ahrum Baek
EKEun-Bin Kwon
Eun-Bin Kwon
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
YCYongmin Chang
Yongmin Chang
The use of cancer-derived exosomes has been studied in several cancer types, but the cancer-targeting efficacy of glioma-derived exosomes has not been investigated in depth for malignant glioblastoma (GBM) cells. In this study, exosomes were derived from U87MG human glioblastoma cells, and selumetinib, a new anticancer drug, was loaded into the exosomes. We observed the tropism of GBM-derived exosomes in vitro and in vivo. We found that the tropism of GBM-derived exosomes is in contrast to the behavior of non-exosome-enveloped drugs and non-GBM-specific exosomes in vitro and in vivo in an animal GBM model. We found that the tropism exhibited by GBM-derived exosomes can be utilized to shuttle selumetinib, with no specific targeting moiety, to GBM tumor sites. Therefore, our findings indicated that GBM-derived exosomes loaded with selumetinib had a specific antitumor effect on U87MG cells and were non-toxic to normal brain cells. These exosomes offer improved therapeutic prospects for glioblastoma therapy.

21 July 2005 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SYSung Ho Yoon
Sung Ho Yoon
CHCheol-Goo Hur
Cheol-Goo Hur
HKHo-Young Kang
Ho-Young Kang
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
TOTae Kwang Oh
Tae Kwang Oh
JKJihyun F Kim
Jihyun F Kim
Background: Pathogenicity islands (PAIs), distinct genomic segments of pathogens encoding virulence factors, represent a subgroup of genomic islands (GIs) that have been acquired by horizontal gene transfer event. Up to now, computational approaches for identifying PAIs have been focused on the detection of genomic regions which only differ from the rest of the genome in their base composition and codon usage. These approaches often lead to the identification of genomic islands, rather than PAIs. Results: We present a computational method for detecting potential PAIs in complete prokaryotic genomes by combining sequence similarities and abnormalities in genomic composition. We first collected 207 GenBank accessions containing either part or all of the reported PAI loci. In sequenced genomes, strips of PAI-homologs were defined based on the proximity of the homologs of genes in the same PAI accession. An algorithm reminiscent of sequence-assembly procedure was then devised to merge overlapping or adjacent genomic strips into a large genomic region. Among the defined genomic regions, PAI-like regions were identified by the presence of homolog(s) of virulence genes. Also, GIs were postulated by calculating G+C content anomalies and codon usage bias. Of 148 prokaryotic genomes examined, 23 pathogenic and 6 non-pathogenic bacteria contained 77 candidate PAIs that partly or entirely overlap GIs. Conclusion: Supporting the validity of our method, included in the list of candidate PAIs were thirty four PAIs previously identified from genome sequencing papers. Furthermore, in some instances, our method was able to detect entire PAIs for those only partial sequences are available. Our method was proven to be an efficient method for demarcating the potential PAIs in our study. Also, the function(s) and origin(s) of a candidate PAI can be inferred by investigating the PAI queries comprising it. Identification and analysis of potential PAIs in prokaryotic genomes will broaden our knowledge on the structure and properties of PAIs and the evolution of bacterial pathogenesis.

1 January 2015 in Korean Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
JKJee Hyun Kim
Jee Hyun Kim
EKEun Joo Kim
Eun Joo Kim
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
YKYong Il Kim
Yong Il Kim
SLSe-Hyung Lee
Se-Hyung Lee
YPYoung Jeung Park
Young Jeung Park
Kim JH, et al. Korean J Ophthalmol. 2015 Aug;29(4):270-279. https://doi.org/10.3341/kjo.2015.29.4.270

1 February 2016 in Cornea
Verified
Journal Article
Open access
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
JJJae-Chang Jung
Jae-Chang Jung
SJSoon-Young Jung
Soon-Young Jung
SYSung Yu
Sung Yu
KLKyoo Won Lee
Kyoo Won Lee
YPYoung Jeung Park
Young Jeung Park
The purpose of this study was to compare the cytotoxicity and antiinflammatory effect of preserved and unpreserved 0.1% fluorometholone (FML). Drug-induced morphological changes and cytotoxicity were examined in human corneal epithelial cells. Dry eye was induced in mice by treatment with 0.2% benzalkonium chloride (BAC) for the first 2 weeks, and then, the eyes (4 groups; Normal saline, BAC, preserved FML, and unpreserved FML) were treated thrice daily with each formulation for the next 2 weeks. Corneal tissues were embedded in paraffin and stained with hematoxylin and eosin for histopathological examination. Immunofluorescence staining was performed for tumor necrosis factor-α, interleukin-6, and human leukocyte antigen-DR. Terminal deoxynucleotidyl transferase dUTP nick end labeling assay was performed to evaluate drug-induced cytotoxicity. BAC and preserved FML caused cell shrinkage and detachment from the plate in a dose-dependent manner, and cell viability decreased significantly. However, cytotoxicity was reduced on treatment with unpreserved FML. Hematoxylin-eosin staining revealed surface desquamation, irregular surface, loss of cell borders, and stromal shrinkage in the group treated with BAC. On BAC exposure, tumor necrosis factor-α, interleukin-6, and human leukocyte antigen-DR were strongly detected, and cytotoxicity was markedly increased, as evidenced by a positive result in the terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Ocular surface damage and inflammation were slightly reduced on treatment with preserved FML. In comparison, unpreserved FML did not induce morphological changes; moreover, decreased cell cytotoxicity and ocular surface inflammation were observed. The cytotoxicity of antiinflammatory eye drops evaluated in this study was induced by the preservative BAC. Accordingly, unpreserved FML is more effective than preserved eye drops in decreasing ocular inflammation.